The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial-Reference-Cited by-同舟云学术

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial

Published:2019-09 Issue:9 Volume:6 Page:735-744
ISSN:2215-0366
Container-title:The Lancet Psychiatry
language:en
Short-container-title:The Lancet Psychiatry

Author:

Davey Christopher G,Chanen Andrew M,Hetrick Sarah E,Cotton Sue M,Ratheesh Aswin,Amminger Günter P,Koutsogiannis John,Phelan Mark,Mullen Edward,Harrison Ben J,Rice Simon,Parker Alexendra G,Dean Olivia M,Weller Amber,Kerr Melissa,Quinn Amelia L,Catania Lisa,Kazantzis Nikolaos,McGorry Patrick D,Berk Michael

Funder

National Health and Medical Research Council (NHMRC)

NHMRC

R.D. Wright Biomedical Research Fellowship

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference39 articles.

1. Global burden of disease in young people aged 10-24 years: a systematic analysis;Gore;Lancet,2011

2. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials;Bridge;JAMA,2007

3. Newer generation antidepressants for depressive disorders in children and adolescents;Hetrick;Cochrane Database Syst Rev,2012